{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:56:37Z","timestamp":1785214597351,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epidemics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.epidem.2024.100776","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:30:48Z","timestamp":1719340248000},"page":"100776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing population-level target product profiles of universal human influenza A vaccines"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5030-0963","authenticated-orcid":false,"given":"Qiqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-3361","authenticated-orcid":false,"given":"Sang Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-3071","authenticated-orcid":false,"given":"Chadi M.","family":"Saad-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Viboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-6876","authenticated-orcid":false,"given":"Nimalan","family":"Arinaminpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3227-5909","authenticated-orcid":false,"given":"Bryan T.","family":"Grenfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.epidem.2024.100776_b1","series-title":"U.S. Influenza Surveillance: Purpose and Methods \u2014 CDC","author":"Anon","year":"2022"},{"issue":"6622","key":"10.1016\/j.epidem.2024.100776_b2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.epidem.2024.100776_b3","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1073\/pnas.1113342109","article-title":"Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza","volume":"109","author":"Arinaminpathy","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"issue":"1","key":"10.1016\/j.epidem.2024.100776_b4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/aje\/kwx037","article-title":"Estimating direct and indirect protective effect of influenza vaccination in the United States","volume":"186","author":"Arinaminpathy","year":"2017","journal-title":"Am. J. Epidemiol.","ISSN":"https:\/\/id.crossref.org\/issn\/1476-6256","issn-type":"print"},{"issue":"164","key":"10.1016\/j.epidem.2024.100776_b5","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2019.0879","article-title":"Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza","volume":"17","author":"Arinaminpathy","year":"2020","journal-title":"J. R. Soc. Interface"},{"issue":"6592","key":"10.1016\/j.epidem.2024.100776_b6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.abm8894","article-title":"A global system for the next generation of vaccines","volume":"376","author":"Arinaminpathy","year":"2022","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.epidem.2024.100776_b7","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1073\/pnas.1321656111","article-title":"Multiannual forecasting of seasonal influenza dynamics reveals climatic and evolutionary drivers","volume":"111","author":"Axelsen","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6410","key":"10.1016\/j.epidem.2024.100776_b8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.aat6030","article-title":"Urbanization and humidity shape the intensity of influenza epidemics in U.S. Cities","volume":"362","author":"Dalziel","year":"2018","journal-title":"Science"},{"issue":"413","key":"10.1016\/j.epidem.2024.100776_b9","doi-asserted-by":"crossref","first-page":"eaan5325","DOI":"10.1126\/scitranslmed.aan5325","article-title":"Evolution-informed forecasting of seasonal influenza A (H3N2)","volume":"9","author":"Du","year":"2017","journal-title":"Sci. Transl. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/1946-6234","issn-type":"print"},{"issue":"48","key":"10.1016\/j.epidem.2024.100776_b10","doi-asserted-by":"crossref","first-page":"16915","DOI":"10.1073\/pnas.0407293101","article-title":"Dynamical resonance can account for seasonality of influenza epidemics","volume":"101","author":"Dushoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6930","key":"10.1016\/j.epidem.2024.100776_b11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature01509","article-title":"Ecological and immunological determinants of influenza evolution","volume":"422","author":"Ferguson","year":"2003","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/1476-4687","issn-type":"print"},{"issue":"26","key":"10.1016\/j.epidem.2024.100776_b12","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1073\/pnas.252512799","article-title":"Dynamics and selection of many-strain pathogens","volume":"99","author":"Gog","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6313","key":"10.1016\/j.epidem.2024.100776_b13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.epidem.2024.100776_b14","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-68636-3","article-title":"Design and analysis of vaccine studies","author":"Halloran","year":"2010"},{"issue":"6","key":"10.1016\/j.epidem.2024.100776_b15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/1474-1741","issn-type":"print"},{"issue":"3","key":"10.1016\/j.epidem.2024.100776_b16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov.","ISSN":"https:\/\/id.crossref.org\/issn\/1474-1784","issn-type":"print"},{"issue":"1","key":"10.1016\/j.epidem.2024.100776_b17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-Cell\u2013based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"10.1016\/j.epidem.2024.100776_b18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58989","article-title":"A Global lmmunological Observatory to meet a time of pandemics","volume":"9","author":"Mina","year":"2020","journal-title":"eLife","ISSN":"https:\/\/id.crossref.org\/issn\/2050-084X","issn-type":"print"},{"issue":"22","key":"10.1016\/j.epidem.2024.100776_b19","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.epidem.2024.100776_b20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/1546-170X","issn-type":"print"},{"issue":"10","key":"10.1016\/j.epidem.2024.100776_b21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nature Med.","ISSN":"https:\/\/id.crossref.org\/issn\/1546-170X","issn-type":"print"},{"key":"10.1016\/j.epidem.2024.100776_b22","series-title":"The probability of epidemic burnout in the stochastic SIR model with demography","author":"Parsons","year":"2023"},{"issue":"5938","key":"10.1016\/j.epidem.2024.100776_b23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.1172330","article-title":"Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics","volume":"325","author":"Pitzer","year":"2009","journal-title":"Science"},{"issue":"47","key":"10.1016\/j.epidem.2024.100776_b24","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/1873-2518","issn-type":"print"},{"issue":"11","key":"10.1016\/j.epidem.2024.100776_b25","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1128\/JVI.03101-13","article-title":"Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model","volume":"88","author":"Price","year":"2014","journal-title":"J. Virol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-538X","issn-type":"print"},{"issue":"1585","key":"10.1016\/j.epidem.2024.100776_b26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1098\/rspb.2005.3335","article-title":"Integrating life history and cross-immunity into the evolutionary dynamics of pathogens","volume":"273","author":"Restif","year":"2006","journal-title":"Proc. R. Soc. Lond. [Biol.]","ISSN":"https:\/\/id.crossref.org\/issn\/0962-8452","issn-type":"print"},{"issue":"12","key":"10.1016\/j.epidem.2024.100776_b27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1098\/rsif.2006.0167","article-title":"Vaccination and the dynamics of immune evasion","volume":"4","author":"Restif","year":"2007","journal-title":"J. R. Soc. Interface","ISSN":"https:\/\/id.crossref.org\/issn\/1742-5689","issn-type":"print"},{"issue":"6518","key":"10.1016\/j.epidem.2024.100776_b28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.abd7343","article-title":"Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years","volume":"370","author":"Saad-Roy","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.epidem.2024.100776_b29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1005204","article-title":"Universal or specific? A modeling-based comparison of broad-spectrum influenza vaccines against conventional, strain-matched vaccines","volume":"12","author":"Subramanian","year":"2016","journal-title":"PLoS Comput. Biol.","ISSN":"https:\/\/id.crossref.org\/issn\/1553-7358","issn-type":"print"},{"issue":"32","key":"10.1016\/j.epidem.2024.100776_b30","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"issue":"9","key":"10.1016\/j.epidem.2024.100776_b31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008583","article-title":"Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine","volume":"16","author":"Viboud","year":"2020","journal-title":"PLOS Pathog.","ISSN":"https:\/\/id.crossref.org\/issn\/1553-7374","issn-type":"print"},{"issue":"6","key":"10.1016\/j.epidem.2024.100776_b32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007989","article-title":"Dynamic interactions of influenza viruses in Hong Kong during 1998\u20132018","volume":"16","author":"Yang","year":"2020","journal-title":"PLoS Comput. Biol.","ISSN":"https:\/\/id.crossref.org\/issn\/1553-7358","issn-type":"print"},{"issue":"7","key":"10.1016\/j.epidem.2024.100776_b33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004383","article-title":"Forecasting influenza epidemics in Hong Kong","volume":"11","author":"Yang","year":"2015","journal-title":"PLoS Comput. Biol.","ISSN":"https:\/\/id.crossref.org\/issn\/1553-7358","issn-type":"print"}],"container-title":["Epidemics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436524000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436524000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:39:55Z","timestamp":1728261595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1755436524000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"alternative-id":["S1755436524000379"],"URL":"https:\/\/doi.org\/10.1016\/j.epidem.2024.100776","relation":{},"ISSN":["1755-4365"],"issn-type":[{"value":"1755-4365","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing population-level target product profiles of universal human influenza A vaccines","name":"articletitle","label":"Article Title"},{"value":"Epidemics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.epidem.2024.100776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100776"}}